Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Shareholder effort to support Moore's plan

It's not just that the Moore Plan is very good for PTSC, the Joint Plan is horrible for PTSC. It relies on Alliacense to continue it's failed "non-commercialization" strategy as a troll. Leckrone remains in place (in the shadows as "The Member") so that nothing can be done that materially affects the business without his approval. It provides blanket releases for the insiders whether they generate $1 of royalty revenue or not (which was NOT in the original Debtor Plan, BTW). It gives prefered treatement to the employees who have failed to generate $1 in MMP revenue over the past year. It puts in Leckrone's hand picked successsor as CEO of TPL, and provides no way forward except for more of the same, which is "Trust us, We're the Troll Alliacense". IMO, this is a better plan for Leckrone than the original Debtor Plan he put out last year. PTSC is represented on the Committee, and they agreed to this? I think shareholders should demand an explanation from management as to why they believe the Joint Plan is better for shareholders than the Moore Plan. It is the basic tenant of every corporation that the management "maximize shareholder wealth". How will the Joint Plan be better than the Moore Plan in achieving that end?

Share
New Message
Please login to post a reply